Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners
Launched by M.D. ANDERSON CANCER CENTER · Dec 4, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how day-to-day stress, social support, and healthy lifestyle choices, like exercise and nutrition, affect African American men who have survived stage 0-III prostate cancer and their partners. The goal is to understand how the way patients cope with stress might influence their health behaviors and those of their partners. By studying both the survivors and their loved ones, researchers hope to learn more about how they can support each other in staying healthy.
To be eligible for this study, participants must be African American adults who have survived prostate cancer (stages 0-III) and have completed any necessary treatments like chemotherapy or radiation. They need to live together with a partner or spouse who is also eligible for the study. Both participants should have smartphones, be able to read and speak English, and not be enrolled in any other health programs. It’s important to note that participants will not need any physical assistance and should not have a history of other cancers or serious medical conditions. Those who join the study can expect to share their experiences and insights about managing stress and healthy living together.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Survivors are eligible if they self-identify as African American adults
- • Had stage 0-III prostate cancer (no restriction on time elapsed since diagnosis)
- • Completed adjuvant therapy (i.e., chemo and/or radiation therapy)
- • Live together with a current partner/spouse who is eligible for the study
- • Do not need physical assistance (e.g., wheelchair, cane)
- • Have a smartphone
- • Can read and speak English
- • Currently are not participating in a health behavior or weight management program
- • Men on active surveillance will be included
- • Partners are eligible if they are adults
- • Partners are eligible if they do not have serious medical conditions (e.g., cancer, congestive heart failure, stroke, and dementia)
- • Partners are eligible if they have a smartphone
- • Partners are eligible if they can read and speak English
- • Partners are eligible if they currently are not participating in a health behavior or weight management program
- • The dyad can be either married or unmarried and same-sex or heterosexual
- Exclusion Criteria:
- • Survivors will be excluded if they had a prior history of other cancer or have metastatic cancer
About M.D. Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Dalnim Cho
Principal Investigator
M.D. Anderson Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials